What is BLAC P/E ratio?

Bellevue Life Sciences Acquisition Corp.'s P/E ratio is 1.23. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is BLAC return on equity (ROE)?

Bellevue Life Sciences Acquisition Corp.'s return on equity (ROE) is 7.91%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Bellevue Life Sciences Acquisition Corp.'s market cap?

Bellevue Life Sciences Acquisition Corp. has a market capitalization of $6.98M.

NASDAQ · Shell Companies

Bellevue Life Sciences Acquisition Corp. (BLAC) Stock

Q: What is Bellevue Life Sciences Acquisition Corp. (BLAC) stock price today?

Bellevue Life Sciences Acquisition Corp. (BLAC) is currently trading at $3.01, down 55.27% today.

$3.01 -55.27% NASDAQ: BLAC Financial Services

Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities.

Valuation

Metric	Value
Price	$3.01
Market Cap	$6.98M
P/E Ratio	1.23
P/B Ratio	0.11
P/S Ratio	2.66
EPS (TTM)	$2.45
52-Week High	$13.40
52-Week Low	$3.01
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	7.91%
ROA	4.60%
ROCE	-12.37%
Gross Margin	22.24%
Operating Margin	-726.07%
Net Margin	301.52%
Debt/Equity	0.00
Current Ratio	0.16

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$3.0M
Operating Profit	$0	$0	$-2.0M	$-4.0M	$-18.0M
Net Profit	$0	$0	$0	$-2.0M	$-29.0M
EPS	$0.00	$0.00	$0.07	$-0.54	$0.00
Op Margin	—	—	—	—	-631.0%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.0M	$1.0M	$37.0M	$2.0M	$2.0M
Total Liabilities	$1.0M	$1.0M	$4.0M	$9.0M	$0
Cash	$0	$0	$0	$0	$2.0M
Borrowings	$0	$1.0M	$0	$2.0M	$0

Latest News

Blackstone Finalizes A$4.3 Billion AI Data Center Loan Amid Record Debt Boom GuruFocus.com · Jul 22, 2026 Blackstone (BX) Expands In India And AI, Is The Stock Cheap? Simply Wall St. · Jul 22, 2026 Stanley Black & Decker (SWK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks · Jul 22, 2026 Are Industrial Products Stocks Lagging RBC Bearings (RBC) This Year? Zacks · Jul 22, 2026 America Movil Q2 Earnings Lag Estimates Despite Revenue Momentum Zacks · Jul 22, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$0	$0	$-1.0M	$-2.0M	$0
Investing Cash Flow	$0	$0	$-34.0M	$36.0M	$0
Financing Cash Flow	$0	$0	$-28.0M	$-34.0M	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$0	$0	$-1.0M	$-2.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.21
EV / EBITDA	-0.51
FCF Yield	-7.15%
Quick Ratio	0.14
Interest Coverage	400.76
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ATIFATIF Holdings Ltd.	$0.64	-12.79%	-2.67	$7.63M	0.00%
BNIXBannix Acquisition Corp.	$3.01	-66.56%	-13.68	$7.65M	0.00%
BRLIBrilliant Acquisition Corporation	$4.70	-45.85%	-0.35	$8.53M	0.00%
CETUCetus Capital Acquisition Corp.	$2.22	-62.18%	—	$8.53M	0.00%
EONR	$0.56	-0.66%	-0.41	$27.85M	0.00%

About Bellevue Life Sciences Acquisition Corp.

Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, or reorganization, with one or more enterprises or organizations within the healthcare domain. This firm, established in 2020, maintains its principal office in Bellevue, Washington, and operates as a subordinate entity of Bellevue Global Life Sciences Investors LLC.

Bellevue Life Sciences Acquisition Corp. is headquartered in US.

Bellevue Life Sciences Acquisition Corp. (BLAC) stock trades at $3.01 with a market capitalization of $6.98M. The stock is valued at a price-to-earnings (P/E) ratio of 1.23, price-to-book of 0.11, price-to-sales of 2.66. Over the past 52 weeks the stock has ranged between $3.01 and $13.40, and currently trades 77.5% below its 52-week high.

On profitability, Bellevue Life Sciences Acquisition Corp. generates a return on equity (ROE) of 7.91%, return on capital employed of -12.37%, an operating margin of -726.07%, a net profit margin of 301.52%.

Official website: www.bellevuespac.com